AQR Arbitrage’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,235
Closed -$5.51K 912
2023
Q1
$5.51K Sell
17,235
-29,207
-63% -$6.86K ﹤0.01% 940
2022
Q4
$2.3K Sell
46,442
-3,554
-7% -$423 ﹤0.01% 1111
2022
Q3
$6K Hold
49,996
﹤0.01% 1226
2022
Q2
$8K Hold
49,996
﹤0.01% 1261
2022
Q1
$10K Buy
+49,996
New +$11.9K ﹤0.01% 1255

Other funds holding CDIOW

AQR Arbitrage's CDIOW Position: Q2 2023 in Review

AQR Arbitrage sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q2 2023, closing a stake of 17,235 shares — an estimated $5.51K sold.

AQR Arbitrage first reported a position in CDIOW in Q1 2022 and held it in 5 quarters. The position peaked at $10K in Q1 2022. 13 funds tracked by Wall St. Rank hold CDIOW as of Q2 2023.

  • AQR Arbitrage reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q2 2023 after selling out during the quarter.
  • AQR Arbitrage sold 17,235 Cardio Diagnostics Holdings Inc Warrant shares in Q2 2023, an estimated $5.51K.
  • AQR Arbitrage first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 5 quarters.
  • AQR Arbitrage's Cardio Diagnostics Holdings Inc Warrant position peaked at $10K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q2 2023.

Based on AQR Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.